Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer von Sartor, Oliver, de Bono, Johann, Chi, Kim N, Fizazi, Karim, Herrmann, Ken, Rahbar, Kambiz, Tagawa, Scott T, Nordquist, Luke T, Vaishampayan, Nitin, El-Haddad, Ghassan, Park, Chandler H, Beer, Tomasz M, Armour, Alison, Pérez-Contreras, Wendy J, DeSilvio, Michelle, Kpamegan, Euloge, Gericke, Germo, Messmann, Richard A, Morris, Michael J, Krause, Bernd J

Volltext

Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225 von Wen, X, Wu, Q P, Ke, S, Ellis, L, Charnsangavej, C, Delpassand, A S, Wallace, S, Li, C

Volltext

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline von GRUNDMAN, Michael, PONTECORVO, Michael J, AGBULOS, Abigail, FLITTER, Matthew L, KRAUTKRAMER, Michael J, SARSOUR, Khaled, SKOVRONSKY, Daniel M, MINTUN, Mark A, SALLOWAY, Stephen P, MURALI DORAISWAMY, P, FLEISHER, Adam S, SADOWSKY, Carl H, NAIR, Anil K, SIDEROWF, Andrew, MING LU, ARORA, Anupa K

Volltext

Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria von Grundman, Michael, Johnson, Keith A., Lu, Ming, Siderowf, Andrew, Dell''Agnello, Grazia, Arora, Anupa K., Skovronsky, Daniel M., Mintun, Mark A., Pontecorvo, Michael J.

Volltext

Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors von Strosberg, Jonathan, El-Haddad, Ghassan, Wolin, Edward, Hendifar, Andrew, Yao, James, Chasen, Beth, Mittra, Erik, Kunz, Pamela L, Kulke, Matthew H, Jacene, Heather, Bushnell, David, O'Dorisio, Thomas M, Baum, Richard P, Kulkarni, Harshad R, Caplin, Martyn, Lebtahi, Rachida, Hobday, Timothy, Delpassand, Ebrahim, Van Cutsem, Eric, Benson, Al, Srirajaskanthan, Rajaventhan, Pavel, Marianne, Mora, Jaime, Berlin, Jordan, Grande, Enrique, Reed, Nicholas, Seregni, Ettore, Öberg, Kjell, Lopera Sierra, Maribel, Santoro, Paola, Thevenet, Thomas, Erion, Jack L, Ruszniewski, Philippe, Kwekkeboom, Dik, Krenning, Eric

Volltext

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors von Strosberg, Jonathan, El-Haddad, Ghassan, Wolin, Edward, Hendifar, Andrew, Yao, James, Chasen, Beth, Mittra, Erik, Kunz, Pamela L, Kulke, Matthew H, Jacene, Heather, Bushnell, David, O’Dorisio, Thomas M, Baum, Richard P, Kulkarni, Harshad R, Caplin, Martyn, Lebtahi, Rachida, Hobday, Timothy, Delpassand, Ebrahim, Van Cutsem, Eric, Benson, Al, Srirajaskanthan, Rajaventhan, Pavel, Marianne, Mora, Jaime, Berlin, Jordan, Grande, Enrique, Reed, Nicholas, Seregni, Ettore, Öberg, Kjell, Lopera Sierra, Maribel, Santoro, Paola, Thevenet, Thomas, Erion, Jack L, Ruszniewski, Philippe, Kwekkeboom, Dik, Krenning, Eric

Volltext

Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality? von Gafita, Andrei, Wang, Hui, Robertson, Andrew, Armstrong, Wesley R, Zaum, Raphael, Weber, Manuel, Yagubbayli, Farid, Kratochwil, Clemens, Grogan, Tristan R, Nguyen, Kathleen, Navarro, Fernando, Esfandiari, Rouzbeh, Rauscher, Isabel, Menze, Bjoern, Elashoff, David, Delpassand, Ebrahim S, Herrmann, Ken, Czernin, Johannes, Hofman, Michael S, Calais, Jeremie, Fendler, Wolfgang P, Eiber, Matthias

Volltext

TH-AB-206-02: Nuclear Medicine Theronostics: Wave of the Future; Pre-Clinical and Clinical Opportunities von Delpassand, E.

Volltext

Alpha‐emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor von Wahba, Andrew, Delpassand, Ebrahim S., Nunez, Rodolfo, Esfandiari, Rouzbeh, Venkatramani, Rajkumar

Volltext

Toward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber von Delpassand, Ebrahim S., Rohren, Eric M., Weber, Wolfgang A., Czernin, Johannes

Volltext

Targeted α-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial von Delpassand, Ebrahim S, Tworowska, Izabela, Esfandiari, Rouzbeh, Torgue, Julien, Hurt, Jason, Shafie, Afshin, Núñez, Rodolfo

Volltext

Targeted α -Emitter Therapy with 212 Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial von Delpassand, Ebrahim S, Tworowska, Izabela, Esfandiari, Rouzbeh, Torgue, Julien, Hurt, Jason, Shafie, Afshin, Núñez, Rodolfo

Volltext

Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States von Delpassand, Ebrahim S, Yazdi, Soheil M, Ghantoji, Shashank, Nakasato, Antonio, Strickland, Corinne, Nunez, Rodolfo, Shafie, Afshin, Cork, Susan, Byrne, Clare, Tang, Jackson, Patel, Jeetvan

Volltext

Effectiveness and Safety of Retreatment with 177 Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States von Delpassand, Ebrahim S, Yazdi, Soheil M, Ghantoji, Shashank, Nakasato, Antonio, Strickland, Corinne, Nunez, Rodolfo, Shafie, Afshin, Cork, Susan, Byrne, Clare, Tang, Jackson, Patel, Jeetvan

Volltext

Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children von Foster, Jennifer H., Sher, Andrew, Seghers, Victor, Poston, Jay, Wells, Donald, Delpassand, Ebrahim S., Potter, Samara, Mahajan, Priya, Venkatramani, Rajkumar

Volltext

Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors von Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., Bushnell, D., O'Dorisio, T. M., Baum, R. P., Kulkarni, H. R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A., Srirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, Kjell, Sierra, M. Lopera, Santoro, P., Thevenet, T., Erion, J. L., Ruszniewski, P., Kwekkeboom, D., Krenning, E.

Volltext

Evaluating Genetic Diversity of Whooper Swan (Cygnus cygnus, Linnaeus, 1758) Colonies in Iran von J. Delpassand, S. M. Ghasempouri

Volltext

Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment von Hamiditabar, Mohammadali, Ali, Muzammil, Roys, Joseph, Wolin, Edward M, OʼDorisio, Thomas M, Ranganathan, David, Tworowska, Izabela, Strosberg, Jonathan R, Delpassand, Ebrahim S

Volltext

Toward Integrated Independence von Delpassand, Ebrahim S, Rohren, Eric M, Weber, Wolfgang A, Czernin, Johannes

Volltext

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [ 64 Cu]Cu-DOTA-TOC von Vahidfar, Nasim, Farzanehfar, Saeed, Abbasi, Mehrshad, Mirzaei, Siroos, Delpassand, Ebrahim S, Abbaspour, Farzad, Salehi, Yalda, Biersack, Hans Jürgen, Ahmadzadehfar, Hojjat

Volltext